Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $2.96M | +50.4K | $58.88 | 50.4K | Dec 6, 2021 | Direct | ||
transaction | ABBV | Common Stock, $0.01 par value | Sale | -$6.04M | -50.4K | -100% | $120.00 | 0 | Dec 6, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Option (Right to buy) | Options Exercise | $0 | -50.4K | -100% | $0.00* | 0 | Dec 6, 2021 | Common stock | 50.4K | $58.88 | Direct | F1 |
Id | Content |
---|---|
F1 | Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).